Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R−/−) Mice
Renata Feuerborn, Manuela Besser, Francesco Potì, et al.
Thrombosis and Haemostasis (2018) Vol. 118, Iss. 08, pp. 1470-1480
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Jan‐Bernd Funcke, Philipp E. Scherer
Journal of Lipid Research (2019) Vol. 60, Iss. 10, pp. 1648-1697
Open Access | Times Cited: 255
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
Josefin Soppert, Michael Lehrke, Nikolaus Marx, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 4-33
Open Access | Times Cited: 241
Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology
Ewelina Józefczuk, Tomasz J. Guzik, Mateusz Siedliński
Pharmacological Research (2020) Vol. 156, pp. 104793-104793
Open Access | Times Cited: 141
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
Marco Piccoli, Federica Cirillo, Andrea Ghiroldi, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 143-143
Open Access | Times Cited: 22
Transendothelial transport of lipoproteins
Erika Jang, Jérôme Robert, Lucia Rohrer, et al.
Atherosclerosis (2020) Vol. 315, pp. 111-125
Closed Access | Times Cited: 66
Apolipoprotein M and sphingosine-1-phosphate complex alleviates TNF-α-induced endothelial cell injury and inflammation through PI3K/AKT signaling pathway
Liu Yang, Tie Li
BMC Cardiovascular Disorders (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 62
Sphingolipid metabolism and signaling in cardiovascular diseases
Sonia Borodzicz-Jażdżyk, Piotr Jażdżyk, Wojciech Łysik, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 30
Sphingosine kinase 1 inhibition aggravates vascular smooth muscle cell calcification
Mehdi Razazian, Sheyda Bahiraii, Isratul Jannat, et al.
Pflügers Archiv - European Journal of Physiology (2025)
Open Access
Walnut oil as a dietary intervention for atherosclerosis: Efficacy and mechanistic pathways
Shujuan Hu, Shiyu Tang, Der–Jenq Liu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2025) Vol. 1870, Iss. 4, pp. 159607-159607
Closed Access
Pseudomonas aeruginosa stimulates nuclear sphingosine-1-phosphate generation and epigenetic regulation of lung inflammatory injury
David L. Ebenezer, Evgeny Berdyshev, Irina Bronova, et al.
Thorax (2019) Vol. 74, Iss. 6, pp. 579-591
Open Access | Times Cited: 46
Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction
Andrei C. Spósito, José Carlos de Lima Júnior, Filipe A. Moura, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 8, pp. 1550-1564
Open Access | Times Cited: 39
Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions
Michele Scuruchi, Francesco Potì, Javier Rodríguez‐Carrio, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2019) Vol. 1865, Iss. 2, pp. 158545-158545
Open Access | Times Cited: 38
Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation
Kazuhiro Ishimaru, Kazuaki Yoshioka, Kuniyuki Kano, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 29
The role of sphingosine 1‐phosphate and its receptors in cardiovascular diseases
Jie Ouyang, Zhihao Shu, Shuhua Chen, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 18, pp. 10290-10301
Open Access | Times Cited: 26
Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases
Owais Mohmad Bhat, Rakeeb Ahmad Mir, Iqra Bashir Nehvi, et al.
IJC Heart & Vasculature (2024) Vol. 53, pp. 101469-101469
Open Access | Times Cited: 2
Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases
Elena M. G. Diarte‐Añazco, Karen Alejandra Méndez‐Lara, Antonio Pérez, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6273-6273
Open Access | Times Cited: 24
Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge
Bisera Stepanovska, Antonia I. Lange, Stephanie Schwalm, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1240-1240
Open Access | Times Cited: 16
Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein
Srividya Velagapudi, Lucia Rohrer, Francesco Potì, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 10
Open Access | Times Cited: 14
Dissecting the Therapeutic Mechanisms of Sphingosine-1-Phosphate Receptor Agonism during Ischaemia and Reperfusion
Georgina Wilkins, Jenny Gilmour, Eirini Giannoudaki, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11192-11192
Open Access | Times Cited: 5
SUMOylation in atherosclerosis
Yi-Zhang Liu, Xuan Xiao, Chu-Ting Hu, et al.
Clinica Chimica Acta (2020) Vol. 508, pp. 228-233
Closed Access | Times Cited: 14
Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by increasing tetrahydrobiopterin via regulation of GTP-cyclohydrolase 1 and reducing uncoupled endothelial nitric oxide synthase activity
Da-Sheng Ning, Jian Ma, Yueming Peng, et al.
Atherosclerosis (2021) Vol. 328, pp. 83-91
Closed Access | Times Cited: 13
Sphingosine 1-Phosphate Metabolism and Signaling
Yan Hu, Kezhi Dai
Advances in experimental medicine and biology (2022), pp. 67-76
Closed Access | Times Cited: 9
Zonation and ligand and dose dependence of sphingosine 1-phosphate receptor-1 signalling in blood and lymphatic vasculature
Ilaria Del Gaudio, Anja Nitzsche, Kevin Boyé, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 1
Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways
Srividya Velagapudi, Dongdong Wang, Francesco Potì, et al.
Cardiovascular Research (2023) Vol. 120, Iss. 5, pp. 476-489
Open Access | Times Cited: 4
The therapeutic potential of sphingolipids for cardiovascular diseases
Sapir Ya’ar Bar, Noam Pintel, Hesen Abd Alghne, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top